Drug Trial Radar · NCT05281328
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Last checked: Nov 19, 2026Latest source record: Jun 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
71
Actual
Start
Jun 28, 2022
Primary completion
Feb 5, 2025
Study completion Aug 2027
Sponsor
- Lead sponsor
- Camurus ABIndustry
- Sponsor type
- Industry
- First posted
- Mar 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the trial is to compare the effectiveness and safety of 2 treatment regimens of CAM2029 (given weekly or every 2 weeks) to placebo in participants with symptomatic PLD, either isolated as in autosomal dominant PLD (ADPLD) or associated with autosomal dominant polycystic kidney disease (ADPKD). In the Treatment Period of the trial, participants will be allocated at random to 1 of the 3 treatment arms in a 1:1:1 ratio. After completing the Treatment Period (53 weeks) participants may proceed to a 120-week open-label extension part of the trial and then only receive the same CAM2029 treatment. The active ingredient in CAM2029, octreotide, is administered as a subcutaneous depot using Camurus' FluidCrystal® technology.
Conditions
- Polycystic Liver Disease
Interventions
CAM2029Drug
SC injection using a pre-filled pen
PlaceboDrug
SC injection using a pre-filled pen
Primary outcomes
What the sponsor says the trial is designed to measure.
- Height-adjusted Total Liver Volume (htTLV)Time frame: From screening until treatment week 53
Locations
11 sites in 4 countries. Site status is shown where the registry gives one.
Mayo Clinic
Rochester, Minnesota
Mount Sinai Hospital
New York, New York
The New York Presbyterian Hospital
New York, New York
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
University of Texas Southwestern Medical Center
Dallas, Texas
Bon Secours Richmond Community Hospital
Richmond, Virginia
University Hospitals KU Leuven
Leuven, Belgium
Hannover Medical School
Hanover, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Universitaetsklinikum Müenster
Münster, Germany
Radboud UMC, Department of Gastroenterology and Hepatology
Nijmegen, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.